A111 INFLIXIMAB FOR INDUCTION OF REMISSION IN CROHN’S DISEASE

BACKGROUND: Crohn’s disease (CD) is a chronic idiopathic disease characterized by transmural inflammation of the gastrointestinal tract. AIMS: To evaluate the efficacy and safety of infliximab (IFX) for induction of remission in CD. METHODS: MEDLINE, EMBASE, the Cochrane Library were searched from d...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Can Assoc Gastroenterol
Prif Awduron: Deol, N, Nguyen, T, Parker, C E, Khanna, R, MacDonald, J, Feagan, B G, Jairath, V
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Poster Presentations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507942/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.112
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg